Search results
How Neuroscience Is Leading the Next Wave of Skin-Care Innovation
PopSugar· 2 days agoFounder Stephanie Lee says neurocosmetics have become more trendy due to better technology and the...
IgG4-Related Disease Affects Men More Often, More Severely
Medscape· 2 days agoA recent study highlighted sex-based differences in manifestations of IgG4-related disease.
Jude Bellingham fans discuss hyperpigmentation over footballer's appearance
Yahoo Life UK· 3 days agoRead more about skin conditions: How a healthy gut microbiome can give you better winter skin (Yahoo...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 3 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...
How AI Is Revolutionizing Drug Development
New York Times· 5 days agoIn high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. Steve Lohr reported from the Terray...
Izokibep Marches on for Psoriatic Arthritis
MedPage Today· 6 days agoAfter 16 weeks of treatment in the randomized, placebo-controlled study, 40% and 43% of patients receiving 160 mg of izokibep weekly or biweekly,...
Here Comes the Sun: We Are Your Summer Skincare Experts
Lancaster Online· 2 days agoSummer is finally here and, for most of us, that means more time in the sun - whether it’s relaxing...
Here Comes the Sun: We Are Your Summer Skincare Experts
Lancaster Online· 2 days agoSummer is finally here and, for most of us, that means more time in the sun - whether it’s relaxing...
Little Rock Black-owned business reflects on history ahead of Juneteenth
KTHV Little Rock· 4 days agoAhead of Juneteenth, one Little Rock Black-owned business is reflecting on history. Specifically,...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 3 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance study, COMMAND2Data showed that clinical remission,
